| Item | Value |
|---|---|
| DrugBank ID | DB01204 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 64 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | relapsing-remitting multiple sclerosis | TxGNN Knowledge Graph |
| 2 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
| 3 | acute myeloblastic leukemia without maturation | TxGNN Knowledge Graph |
| 4 | inherited acute myeloid leukemia | TxGNN Knowledge Graph |
| 5 | acute myeloid leukemia with t(6;9)(p23;q34) | TxGNN Knowledge Graph |
| 6 | acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph |
| 7 | therapy related acute myeloid leukemia and myelodysplastic syndrome | TxGNN Knowledge Graph |
| 8 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph |
| 9 | acute myeloid leukemia with NPM1 somatic mutations | TxGNN Knowledge Graph |
| 10 | acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph |
| 11 | acute myeloid leukemia with CEBPA somatic mutations | TxGNN Knowledge Graph |
| 12 | myeloid leukemia | TxGNN Knowledge Graph |
| 13 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph |
| 14 | acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | TxGNN Knowledge Graph |
| 15 | acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph |
| 16 | unclassified acute myeloid leukemia | TxGNN Knowledge Graph |
| 17 | relapsing-remitting multiple sclerosis | TxGNN Knowledge Graph |
| 18 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
| 19 | acute myeloblastic leukemia without maturation | TxGNN Knowledge Graph |
| 20 | inherited acute myeloid leukemia | TxGNN Knowledge Graph |
| 21 | acute myeloid leukemia with t(6;9)(p23;q34) | TxGNN Knowledge Graph |
| 22 | acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph |
| 23 | therapy related acute myeloid leukemia and myelodysplastic syndrome | TxGNN Knowledge Graph |
| 24 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph |
| 25 | acute myeloid leukemia with NPM1 somatic mutations | TxGNN Knowledge Graph |
| 26 | acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph |
| 27 | acute myeloid leukemia with CEBPA somatic mutations | TxGNN Knowledge Graph |
| 28 | myeloid leukemia | TxGNN Knowledge Graph |
| 29 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph |
| 30 | acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | TxGNN Knowledge Graph |
| 31 | acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph |
| 32 | unclassified acute myeloid leukemia | TxGNN Knowledge Graph |
| 33 | relapsing-remitting multiple sclerosis | TxGNN Knowledge Graph |
| 34 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
| 35 | acute myeloblastic leukemia without maturation | TxGNN Knowledge Graph |
| 36 | inherited acute myeloid leukemia | TxGNN Knowledge Graph |
| 37 | acute myeloid leukemia with t(6;9)(p23;q34) | TxGNN Knowledge Graph |
| 38 | acute myeloid leukemia with t(9;11)(p22;q23) | TxGNN Knowledge Graph |
| 39 | therapy related acute myeloid leukemia and myelodysplastic syndrome | TxGNN Knowledge Graph |
| 40 | acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) | TxGNN Knowledge Graph |
| 41 | acute myeloid leukemia with NPM1 somatic mutations | TxGNN Knowledge Graph |
| 42 | acute myeloid leukemia with minimal differentiation | TxGNN Knowledge Graph |
| 43 | acute myeloid leukemia with CEBPA somatic mutations | TxGNN Knowledge Graph |
| 44 | myeloid leukemia | TxGNN Knowledge Graph |
| 45 | acute myeloid leukemia with t(8;21)(q22;q22) translocation | TxGNN Knowledge Graph |
| 46 | acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | TxGNN Knowledge Graph |
| 47 | acute myeloblastic leukemia with maturation | TxGNN Knowledge Graph |
| 48 | unclassified acute myeloid leukemia | TxGNN Knowledge Graph |
| 49 | relapsing-remitting multiple sclerosis | TxGNN Knowledge Graph |
| 50 | acute myeloid leukemia with t(8;16)(p11;p13) translocation | TxGNN Knowledge Graph |
(Showing top 50 of 64 predictions)
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.